Ontology of Cardiovascular Drug Adverse Events
Abbreviation: OCVDAE
Homepage http://bioportal.bioontology.org/ontologies/OCVDAE
Countries that developed this resource China , United States
Created in 2016
Taxonomic range
Knowledge Domains
Subjects
User-defined Tags
How to cite this record FAIRsharing.org: OCVDAE; Ontology of Cardiovascular Drug Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.a557he; Last edited: Jan. 8, 2019, 1:38 p.m.; Last accessed: Dec 11 2019 4:58 p.m.
Record added: Oct. 24, 2017, 9:41 a.m.
Record updated:
Feb. 19, 2018, 7:43 p.m. by The FAIRsharing Team.
| support email | Yongqun Oliver He |
| online documentation | GitHub Repository |
Additional Information
| Contact | Liwei Wang |
External Links
| Bioportal | http://bioportal.bioontology.org/ontologies/OCVDAE |
No XSD schemas defined
Conditions of Use
Ontology-based systematical representation and drug class effect analysis of package insert-reported adverse events associated with cardiovascular drugs used in China.
Wang L,Li M,Xie J,Cao Y,Liu H,He Y
Sci Rep 2017
View in BioPortal.
Reporting Guidelines
No guidelines defined
Terminology Artifacts
Models and Formats
No syntax standards defined
Identifier Schemas
No identifier schema standards defined
Metrics
No metrics standards defined
No Related Databases
This record is not implemented by any policy.
Record Maintainer
This record is in need of a maintainer. If you login, you'll be able to claim this record.
Maintains
Department of Medical Informatics, School of Public Health, Jilin University, Changchun, China (University)
Hebei Medical University, Shijiazhuang, Hebei Province, China (University)
Department of Health Sciences Research, Mayo Clinic, Rochester, USA (Company)
He Group, University of Michigan Medical School, Ann Arbor, USA (Lab)
